Effectiveness of Prenatal Screening Tests on Predicting Cardiac Anomalies

Files

Authors

Stephanie Y. Wong, Oakland University William Beaumont School of Medicine Medical Student
Zeynep Alpay Savasan, Beaumont Health

Description

INTRODUCTION
Congenital heart disease (CHD) is the leading cause of birth defect-associated infant death. With 1 in 111 newborns born with CHD and an elevated infant mortality rate of 30-50%, early detection is imperative. Current prenatal screening mainly focuses on detecting chromosomal anomalies. However, the accuracy of these exams on detecting fetal cardiac abnormalities is not well researched. The primary goal of this study is to compare three prenatal screening tests’ potential, i.e anatomy ultrasound, nuchal translucency (NT), and cell-free DNA (cfDNA), in identifying risk for fetal cardiac anomalies.

Publication Date

5-2-2022

Keywords

prenatal screening, cardiac anomalies

Disciplines

Obstetrics and Gynecology

Recommended Citation

Wong SY, Alpay-Savasan Z. Effectiveness of prenatal screening tests on predicting cardiac anomalies. Poster presented at: Oakland University William Beaumont School of Medicine Embark Capstone Colloquium; 2022 May 2; Rochester Hills, MI.

Comments

The Embark Capstone Colloquium at the Oakland University William Beaumont School of Medicine, Rochester Hills, MI, May 2, 2022.